Local complement activation and modulation in mucosal immunity.

Complosome SARS-CoV-2 alloimmunity colitis pneumonia transplantation

Journal

Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742

Informations de publication

Date de publication:
03 Jun 2024
Historique:
received: 01 01 2024
revised: 24 05 2024
accepted: 29 05 2024
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 5 6 2024
Statut: aheadofprint

Résumé

The complement system is an evolutionarily conserved arm of innate immunity, which forms one of the first lines of host response to pathogens, and assists in the clearance of debris. A deficiency in key activators/amplifiers of the cascade results in recurrent infection, whereas a deficiency in regulating the cascade predisposes to accelerated organ failure, as observed in colitis and transplant rejection. Given that there are over 60 proteins in this system, it has become an attractive target for immunotherapeutics, many of which are FDA approved or in multiple phase 2/3 clinical trials.Moreover, there have been key advances in the last few years in the understanding of how the complement system operates locally in tissues, independent of its activities in the circulation. In this review, we will put into perspective the abovementioned discoveries to optimally modulate the spatiotemporal nature of complement activation and regulation at mucosal surfaces.

Identifiants

pubmed: 38838816
pii: S1933-0219(24)00047-3
doi: 10.1016/j.mucimm.2024.05.006
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Devesha H Kulkarni (DH)

Divisions of Gastroenterology, Washington University School of Medicine, St. Louis, United States.

Marick Starick (M)

Divisions of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, United States.

Rafael Aponte Alburquerque (R)

Divisions of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, United States.

Hrishikesh S Kulkarni (HS)

Divisions of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, United States. Electronic address: hkulkarn@wustl.edu.

Classifications MeSH